Verbeek, J. G., Azarang, L., Pilli, L. E., De Jong, V. M., Jager, A., Linn, S. C., . . . Van Harten, W. H. (2024). High-dose chemotherapy for patients with stage III breast cancer with homologous recombination deficiency: A discrete choice experiment among healthcare providers. Acta oncologica, 63(1), 701-709. https://doi.org/10.2340/1651-226X.2024.40276
Citace podle Chicago (17th ed.)Verbeek, Joost G.E., Leyla Azarang, Luis E. Pilli, Vincent M.T De Jong, Agnes Jager, Sabine C. Linn, Valesca P. Retèl, a Wim H. Van Harten. "High-dose Chemotherapy for Patients with Stage III Breast Cancer with Homologous Recombination Deficiency: A Discrete Choice Experiment Among Healthcare Providers." Acta Oncologica 63, no. 1 (2024): 701-709. https://doi.org/10.2340/1651-226X.2024.40276.
Citace podle MLA (9th ed.)Verbeek, Joost G.E., et al. "High-dose Chemotherapy for Patients with Stage III Breast Cancer with Homologous Recombination Deficiency: A Discrete Choice Experiment Among Healthcare Providers." Acta Oncologica, vol. 63, no. 1, 2024, pp. 701-709, https://doi.org/10.2340/1651-226X.2024.40276.